Reid Merryman, MD

Medical Oncology

Reid Merryman, MD

View Full profile

Related Videos

Reid W. Merryman, MD discusses results of a multicenter phase II trial Video

Reid W. Merryman, MD discusses results of a multicenter phase II trial

Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma

Reid Merryman, MD, on ct-DNA & Diffuse Large B-cell Lymphoma Video

Reid Merryman, MD, on ct-DNA & Diffuse Large B-cell Lymphoma

At #ASH23, Reid Merryman, MD, Dana-Farber, discussed results from a pilot study that uses circulating tumor DNA to reliably predict relapse in patients with diffuse large B-cell lymphoma.